Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
multiple organ failure
MeSH D009102 - multiple organ failure
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012769:
Shock
92 Companies
18 Drugs
$
Success rate
D009102:
Multiple organ failure
1 Company
1 Drug
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Eli Lilly
Drotrecogin alfa (activated)
Xigris
2002-08-22
Clinical Trials
Historical Success Rate
Phase 1
100
%
2/2
Phase 2
38
%
5/13
Phase 3
0
%
0/7
Approved:
0
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Eli Lilly
Drotrecogin alfa (activated)
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use